<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: black swan</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'black swan'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22black+swan%22&t=%22black+swan%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:59:10 +0100</lastBuildDate>
        <item>
            <title>Eating Your Shadow, In Honor of Groundhog Day</title>
            <link>http://www.medworm.com/index.php?rid=4429058&amp;cid=t_143224_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F02%2F02%2Feating-your-shadow-in-honor-of-groundhog-day%2F</link>
            <description>To confront a person with his shadow is to show him his own light. Once one has experienced a few times what it is like to stand judgingly between the opposites, one begins to understand what is meant by the self. Anyone who perceives his shadow and his light simultaneously sees himself from two sides and thus gets in the middle.
— Carl Gustav Jung
The despised self, the disowned self, and the shadow: By any name psychology has acknowledged the dark side of our personality in many forms. It is also in literature (Dr. Jekyll and Mr. Hyde) and at the movies (Black Swan) we may first come to know the shadow. Psychology has long since been trying to get us to deal with it. There is a way. The ultimate way of coping with it is to eat it.
The Shadow Effect, by the leading spiritual healers of ...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4429058</comments>
            <pubDate>Wed, 02 Feb 2011 16:05:52 +0100</pubDate>
            <guid isPermaLink="false">4429058</guid>        </item>
        <item>
            <title>Best of Our Blogs: January 18, 2011</title>
            <link>http://www.medworm.com/index.php?rid=4361068&amp;cid=t_143224_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2011%2F01%2F18%2Fbest-of-our-blogs-january-18-2011%2F</link>
            <description>No matter who we are, where we live, how much money we have or what we do for a living, we all essentially want the same thing. We want to feel validated that our worries, feelings and emotions are justified. We want to be seen, heard and felt valued for who we are. We want to know that how we feel and what we think is normal. And most important, we want to be both loved and understood.
Knowing these things, can we change the way we perceive our relationships? Can we change the way we treat ourselves and others?
That&amp;#8217;s a hope I have and a realistic resolution you could have for 2011. A simple change to gain a worthy result.
Recently, my great aunt was snappy on the phone with my dad, I took the chance and spoke to her, validating her concerns, calming her fears, and noticed an instan...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4361068</comments>
            <pubDate>Tue, 18 Jan 2011 11:52:11 +0100</pubDate>
            <guid isPermaLink="false">4361068</guid>        </item>
        <item>
            <title>Sketching a More Realistic Portrait of Science in Practice</title>
            <link>http://www.medworm.com/index.php?rid=3467813&amp;cid=t_143224_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F04%2F14%2Fsketching-a-more-realistic-portrait-of-science-in-practice%2F</link>
            <description>One of the most notable developments in the book business in the last decade or so has been the rise of the likes of Malcolm Gladwell (The Tipping Point, Blink, Outliers, etc.), Steven Leavitt, Stephen Dubner (Freakonomics, SuperFreakonomics), Ian Ayres (Super Crunchers), and Nicholas Taleb (Fooled by Randomness, The Black Swan). All of their books are best-sellers; all of them have been embraced as business books, management books, and general interest books. For anyone trained in the sciences, this is a thrilling development, a sure sign that scientific thinking has enthralled the public.
This welcome development was an inspiration for writing my new book, titled Numbers Rule Your World: The Hidden Influence of Probability and Statistics on Everything You Do (McGraw-Hill, 2010). As a lon...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3467813</comments>
            <pubDate>Wed, 14 Apr 2010 10:02:20 +0100</pubDate>
            <guid isPermaLink="false">3467813</guid>        </item>
        <item>
            <title>Open innovation in drug design? - I do not think so!</title>
            <link>http://www.medworm.com/index.php?rid=2312608&amp;cid=t_143224_107_f&amp;fid=36698&amp;url=http%3A%2F%2Fminingdrugs.blogspot.com%2F2009%2F03%2Fopen-innovation-in-drug-design-i-do-not.html</link>
            <description>Triggered by slides and a discussion from Cameron Neylon was I wondering, to which degree people believe in open innovation for the drug design community?Though the principle seems valid for a few software companies, is there little support for life sciences on this topic.&quot;It's an area that's just not been explored much. The usual flow is very much linear. Can be developed in academia, is then licensed via tech transfer.&quot; [Deepak]&quot;The question is whether a business can make money by a route that doesn't involve patents (or copyright). There are examples of that, O'Reilly publishing being the most obvious but they are pretty thin.&quot; [Cameron]In other words, if you do not need the money, do whatever you like openly. If you need the money, e.g. for clinical trials, then please make sure stayin...</description>
            <author>Mining Drug Space</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2312608</comments>
            <pubDate>Mon, 30 Mar 2009 17:30:00 +0100</pubDate>
            <guid isPermaLink="false">2312608</guid>        </item>
        <item>
            <title>What does the Black Swan have to do with pharma?</title>
            <link>http://www.medworm.com/index.php?rid=825471&amp;cid=t_143224_132_f&amp;fid=35011&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2Fmndoci%2F%7E3%2F149015443%2F</link>
            <description>(Via Bio-IT World) Apparently, Frank Douglas, former CEO of Aventis, brought up the metaphor of Nassim Nicholas Taleb&amp;#8217;s controversial idea and it&amp;#8217;s potential impact on the biopharma industry. Speaking as the opening keynote at the DDT conference, Douglas predicted that in 10 years the industry would look very different. 
One of the potential Black Swan scenario&amp;#8217;s that he presented was one where there would be just 3-4 top pharma, complemented by a number of small specialty players, strategic global outsourcing, increased emphasis on virtual research, and VC firms acting as research translators. Is it me or is this scenario a eerily similar to the enterprise software industry. And is this even a Black Swan scenario? If one looks at what&amp;#8217;s happened over the past few y...</description>
            <author>business|bytes|genes|molecules</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=825471</comments>
            <pubDate>Tue, 28 Aug 2007 01:06:33 +0100</pubDate>
            <guid isPermaLink="false">825471</guid>        </item>
    </channel>
</rss>

